Morgan RD, Clamp AR, White DJ, Price M, et al. Multi-maintenance olaparib therapy in relapsed, germline BRCA1/2-mutant high-grade serous ovarian cancer (MOLTO): a phase II trial. Clin Cancer Res 2023 Feb 17:CCR-22-3282. doi: 10.1158/1078-0432.CCR-22-3282.
PMID: 36799931